ISIN | CH0590186661 |
---|---|
Valor Number | 59018666 |
Bloomberg Global ID | SPISI SW |
Fund Name | UBS ETF (CH) - SPI® ESG (CHF) A-acc |
Fund Provider |
UBS Fund Management (Switzerland) AG
Basel, Switzerland Phone: +41 61 288 75 01 E-Mail: sh-ubs-funds-feedback@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Fund Management (Switzerland) AG |
Representative in Switzerland | |
Distributor(s) |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Asset Class | Equities |
EFC Category | Equity Switzerland |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | n/a |
Peculiarities |
Current Price * | 15.24 CHF | 21.11.2024 |
---|---|---|
Previous Price * | 15.18 CHF | 20.11.2024 |
52 Week High * | 16.27 CHF | 02.09.2024 |
52 Week Low * | 13.81 CHF | 28.11.2023 |
NAV * | 15.24 CHF | 21.11.2024 |
Issue Price * | 15.24 CHF | 21.11.2024 |
Redemption Price * | 15.24 CHF | 21.11.2024 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 1,153,330,755 | |
Unit/Share Assets *** | 1,153,330,755 | |
Trading Information SIX |
YTD Performance | +6.76% |
29.12.2023 - 21.11.2024
29.12.2023 21.11.2024 |
---|---|---|
1 month | -5.25% |
21.10.2024 - 21.11.2024
21.10.2024 21.11.2024 |
3 months | -4.83% |
21.08.2024 - 21.11.2024
21.08.2024 21.11.2024 |
6 months | -2.99% |
21.05.2024 - 21.11.2024
21.05.2024 21.11.2024 |
1 year | +10.00% |
21.11.2023 - 21.11.2024
21.11.2023 21.11.2024 |
2 years | +10.96% |
21.11.2022 - 21.11.2024
21.11.2022 21.11.2024 |
3 years | -1.28% |
22.11.2021 - 21.11.2024
22.11.2021 21.11.2024 |
5 years | +19.22% |
23.02.2021 - 21.11.2024
23.02.2021 21.11.2024 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Novartis AG Registered Shares | 12.63% | |
---|---|---|
Roche Holding AG | 11.94% | |
Nestle SA | 9.73% | |
ABB Ltd | 6.06% | |
Zurich Insurance Group AG | 6.02% | |
UBS Group AG | 4.41% | |
Compagnie Financiere Richemont SA Class A | 4.34% | |
Swiss Re AG | 2.85% | |
Holcim Ltd | 2.79% | |
Givaudan SA | 2.69% | |
Last data update | 19.11.2024 |
TER | 0.15% |
---|---|
TER date | 30.06.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.15% |
Ongoing Charges *** | 0.15% |
SRRI ***
|
|
SRRI date *** | 31.10.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |